Key Takeaways
- Apple shares surged over 3% after its new iPhone launch, hitting a seven-month high.
- Global bond markets experienced a significant sell-off, impacting rate-sensitive financial sectors.
- President Trump announced progress on a TikTok deal, but policy analysts expressed skepticism on specifics.
- Gold, silver, and uranium markets rallied, with the GDX Gold Miner Index reaching an all-time high.
- Novo Nordisk showed strong GLP-1 drug data, while Eli Lilly's oral drug also demonstrated positive results.
- An expert warned of a bearish outlook for the U.S. EV market, citing consumer credit and infrastructure issues.
Deep Dive
- Apple shares gained over 3% after its latest iPhone launch, reaching a seven-month high.
- JP Morgan raised its price target by nearly 10%, citing strong demand and positive multi-year growth outlook.
- CNBC reported significant lines and high demand for the new iPhones, particularly the more expensive Pro models, in Manhattan.
- Analysts suggest this iPhone cycle could serve as a bridge to future innovations like foldable phones and AI integration.
- Oracle surged, being rewarded for potential AI offerings, possibly spurred by Google's antitrust issues.
- The company's valuation has transitioned from a value stock to a growth stock valuation.
- Analysts questioned the profitability of Oracle's new deals amidst its recent performance.
- Global bonds are selling off with rising yields in the U.S., U.K., Germany, and Japan following the Fed's rate cut.
- This sell-off is impacting rate-sensitive sectors like banks and homebuilders.
- European banks, tracked by the EU FN ETF, are up 46% year-to-date, significantly outperforming the XLF's 12% gains.
- President Trump indicated approval for a TikTok deal to transfer to U.S. investors, with plans for U.S. control over the algorithm.
- Senior policy analyst DeWardrick McNeil expressed skepticism, noting U.S. law requires complete divestiture, including the algorithm.
- McNeil suggested China's motivation is primarily for optics and demonstrating leverage in protecting its companies under its own laws.
- The host expressed concern over a delayed $400 million U.S. weapons package for Taiwan and China's subsequent actions.
- China recently directed companies to avoid purchasing NVIDIA chips, raising questions about U.S.-China trade relations.
- A panelist suggested China's chip purchase restrictions, while expected due to strategic AI interests, may not significantly impact major U.S. chipmakers like NVIDIA and Broadcom.
- Gold, silver, and uranium showed strong performance; the GDX Gold Miner Index reached an all-time high.
- The Uranium ETF (URA) saw an 8% jump, attributed to a potential squeeze and holding significant positions in Cameco and Oclo.
- Analysts upgraded gold price targets, with China's increased FX reserves including gold noted as a trend.
- Novo Nordisk had its best week since February after reporting significant weight loss with a higher dose of its obesity pill.
- Eli Lilly's stock remained nearly flat despite positive data on its oral drug, which outperformed lower doses of Novo's pill in a head-to-head trial.
- Dr. Kavita Patel noted a shift in investor sentiment towards Novo Nordisk, emphasizing its focus beyond obesity to cardiometabolic disease.
- Mike suggested a bullish reversal for Novo Nordisk stock if it breaks above $64-$65, particularly if it enters new markets like sleep apnea.
- Lox Ganapathy of Unicus Research warned the U.S. is not ready for an EV boom, citing past short successes in the EV space.
- Concerns were raised about ChargePoint and the failure of companies like Fisker and Faraday Future to scale cost-effectively.
- Consumer frustration with EV charging and a deterioration in consumer credit were highlighted, with 60% of consumers living paycheck to paycheck.
- Auto loan originations have increased, with a recent spike in delinquencies and charge-offs in asset-backed securities.